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Evaluation of renal allograft function early
after transplantation with diffusion-weighted
MR imaging
Abstract Aims: To determine the
inter-patient variability of apparent
diffusion coefficients (ADC) and con-
current micro-circulation contribu-
tions from diffusion-weighted MR
imaging (DW-MRI) in renal allografts
early after transplantation, and to
obtain initial information on whether
these measures are altered in histo-
logically proven acute allograft rejec-
tion (AR). Methods: DW-MRI was
performed in 15 renal allograft reci-
pients 5–19 days after transplantation.
Four patients presented with AR and
one with acute tubular necrosis (ATN).
Total ADC (ADCT) was determined,
which includes diffusion and micro-
circulation contributions. Further-
more, diffusion and micro-circulation
contributions were separated, yielding
the “perfusion fraction” (FP), and
“perfusion-free” diffusion (ADCD).
Results: Diffusion parameters in the
ten allografts with stable function early
after transplantation demonstrated low
variabilities. Values for ADCT and
ADCD were (×10
−5 mm2/s) 228±14
and 203±9, respectively, in cortex and
226±16 and 199±9, respectively, in
medulla. FP values were 18±5% in
cortex and 19±5% in medulla. FP
values were strongly reduced to less
than 12% in cortex and medulla of
renal transplants with AR and ATN. FP
values correlated with creatinine
clearance. Conclusion: DW-MRI
allows reliable determination of diffu-
sion and micro-circulation contribu-
tions in renal allografts shortly after
transplantation; deviations in AR
indicate potential clinical utility of this
method to non-invasively monitor
derangements in renal allografts.
Keywords Diffusion . Perfusion .
Kidney . Acute rejection . Allograft .
Transplantation
Introduction
Intense allograft monitoring and early characterisation of
dysfunction after renal transplantation are important to
allow initiation of appropriate treatment and to improve the
rate of successful outcome. Among others, acute rejection
(AR) remains a major complication after renal transplan-
tation, which may reduce both short- and long-term graft
survival [1]. Until now, no reliable and accurate non-
invasive clinical methods were available to diagnose and
distinguish between different renal allograft derangements
such as AR and acute tubular necrosis (ATN).
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Diffusion-weighted MR imaging (DW-MRI) is a
promising non-invasive MR imaging method to obtain
functional information about the renal allograft. Its
application may therefore be instrumental in monitoring
patients early after kidney transplantation. DW-MRI yields
a total “apparent diffusion coefficient” (ADCT) that
provides information on diffusion properties, but also
includes contributions from concurrent micro-circulation
[2]. Provided diffusion and micro-circulation contributions
can be separated, DW-MRI may in addition provide
information on micro-circulation, quantified with the
“perfusion fraction” (FP), and “perfusion-free” diffusion
(ADCD).
Compared with the brain, in which DW-MRI is routinely
performed, applications in abdominal organs are only
currently evolving because of a number of technical
challenges, including respiratory and cardiac motion as
well as susceptibility artefacts [3–5]. Although DW-MRI
has been successfully applied in a number of studies for
functional characterisation of native kidneys (for an
overview see [6]), to date only one animal study has
examined transplanted kidneys with DW-MRI [7], and
only one study in human transplanted kidneys has been
published, demonstrating the feasibility and reproducibility
of DW-MRI in allografts with stable function at least
4 months after transplantation [8]. In addition, the latter
DW-MRI study was the first to separately analyse the
micro-circulation contribution in stable human transplanted
kidneys. No DW-MRI study has yet been performed in
human renal allografts shortly after transplantation, neither
in healthy nor diseased patients. Previous studies have
suggested that complications in renal allografts, like acute
rejection, may lead to altered blood flow and/or changes in
reabsorption and concentration-dilution function [9, 10].
The separation of diffusion and micro-circulation contribu-
tions may therefore be especially interesting in this
condition.
Almost all previously published DW-MRI measure-
ments in kidneys were performed at the lower field strength
of 1.5 T, while 3-T MRI is being introduced more and more
into clinical routine, mostly because of higher sensitivity
[5]. Previously, we showed that DW-MRI obtained on 1.5-
T MRI in transplanted kidneys with good renal function
about 9 months after transplantation yields stable and
reproducible values for the total apparent diffusion coef-
ficient (ADCT), corresponding to the commonly deter-
mined diffusion parameter, the “perfusion-free” diffusion
coefficient (ADCD) and—although less stable—the micro-
circulation contribution [8].
The main goals of the current DW-MRI study on 3-T
MRI in renal allografts shortly after transplantation were to
determine the inter-patient variability of diffusion para-
meters, including perfusion contributions, and to gain
initial information on whether these measures are altered in
histologically proven acute allograft rejection, providing a
first impression of the sensitivity of the method.
Materials and methods
Patients and volunteers
The local ethics committee approved the study proto-
col and all participants provided written informed
consent.
The study group comprised 15 renal transplant
patients (10 men, 5 women; mean age 47±11 years;
age range 31–65 years), 11 first, 2 second and 2 third
transplantations (Table 1). All transplant recipients
eligible for the study and providing written informed
consent were included in the study over a total period of
7 months. Mean time between transplantation and MRI
was 10±4 days (range 5–19 days). Delayed graft
function occurred in four patients. Six patients received
a kidney transplant biopsy which showed AR in four
patients (two patients with signs of acute humoral
rejection, positive C4d staining and presence of donor-
specific serum antibodies, and two patients with acute
cellular rejection), ATN/cholesterol embolism in one
patient, and no AR or ATN, but signs of a donor-
derived hyaline arteriolosclerosis in one patient. The last
patient was considered to have a normal functioning
transplant because no other clinical signs of allograft
dysfunction were detected. In addition, 9 of the 15
patients demonstrated no clinical sign of major allograft
complications and these patients were also considered to
have a stable transplant function. Histological diagnosis
was assessed according to the Banff criteria [11–13].
For those patients undergoing a biopsy, the MR
examination was performed within 5 days of the biopsy.
No other imaging modality for detection of graft
rejection was performed.
The subjects were told to eat and drink moderately;
however, exact control of their hydration status was
unnecessary, because only a low impact on diffusion
results under normal conditions was expected [6]. All
patients received triple immunosuppressive therapy
based on a combination of cyclosporine starting at day
1 post-operatively, mycophenolate mofetil or mycophe-
nolic acid and prednisone. Induction therapy was
applied with basiliximab (Simulect®) on day 0 and
day 4 in all patients. One patient (S13) with a panel
reactive antibody (PRA) of 63% at transplantation
additionally received intravenous immunoglobulin ther-
apy (Octagam® Octapharma, Lachen, Switzerland) from
day 0 to 3 post-transplantation.
Anti-rejection therapy consisted of at least three intra-
venous methylprednisolone pulses in all patients with signs
of AR, and additional plasmapheresis treatment for the two
patients with acute humoral rejection.
Serum creatinine (s-Crea) concentrations were obtained
from all subjects on the day of the MR examination and
were used to calculate the creatinine clearance (eGFRc)
using the Cockcroft–Gault formula [14].
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After 1 year of clinical post-transplant follow-up, renal
function was preserved in 13 patients, one kidney with a
previous severe acute rejection episode had to be removed
(S14), one patient died from an infectious complication
unrelated to allograft function (S15). Follow-up examina-
tions did not include DW-MRI.
MR investigations
The MR measurements were performed on a 3-T MRI
system (TIM-Trio; Siemens, Erlangen, Germany) using a
combination of a spine coil and a phased array body coil
with six elements.
Before the patient investigations, the DW-MRI
measurement parameters were optimised to achieve
sufficient image quality, which is challenging in the
abdomen, especially at higher field strengths. Optimisa-
tion included reduction of echo times and geometric
distortions by selection of bandwidth or parallel imaging
acceleration factor, or evaluation of the benefit using a
dielectric pad to reduce signal voids from dielectric
effects [15]. Morphological imaging included coronal
T2-weighted half-Fourier acquisition single-shot turbo
spin-echo (HASTE) imaging, and axial and coronal T1-
weighted fast low angle shot (FLASH) gradient-echo
imaging. For DW-MRI, a coronal diffusion-weighted
multisection single-shot echo-planar imaging sequence
was applied. In order to be able to separate micro-
circulation from diffusion contributions, ten diffusion
gradient b values between 0 and 700 s/mm2 were
applied (0, 10, 20, 50, 100, 180, 300, 420, 550, 700 s/
mm2). The maximum b value was chosen based on
previously determined renal ADC values leaving
sufficient signal clearly above noise level. The b values
were spaced non-equidistantly with several low b
values, to account for the fast-decaying contribution
from micro-circulation.
The following imaging parameters were used: 11
slices with a thickness of 5 mm and an intersection gap
of 1 mm, field of view = 400×400 mm2, matrix = 128×
128, six averages, bandwidth = 2,300 Hz/pixel, voxel
size = 3.1×3.1×5.0 mm3, phase encoding direction RL.
The diffusion gradients were applied in three orthogonal
directions and subsequently averaged, minimising ef-
fects of diffusion anisotropy. Parallel imaging (iPAT,
GRAPPA) with an acceleration factor of 3 was applied.
Respiratory triggering was used to reduce motion
artefacts with a minimum TR of 2,800 ms and TE of
64 ms. Slice positioning was identical to the coronal T1-
weighted sequence. Minimum acquisition time was
8 min, depending on the breathing cycle. The entire
MR examination including positioning, morphological
imaging and DW-MRI lasted about 30 min.
Image analysis
All participants’ studies were included in the analysis. The
data were evaluated on an independent workstation using a
home-built IDL program (Interactive Data Language, RSI,
Boulder, CO, USA).
Morphological evaluation
The morphological images were read by an experienced
radiologist, subspecialised in urogenital radiology. The
findings are summarised in Table 1.
DW-MRI evaluation
DW-MRI findings were analysed completely blinded with
respect to all clinical findings to eliminate any bias.
Processing of the DW-MRI data was performed on a pixel-
by-pixel basis in two different ways as previously
described [8]. In brief: (1) A single ADC value (ADCT)
was calculated from all b values using a monoexponential
fitting model and includes contributions from both diffu-
sion and perfusion. This method corresponds to the
commonly applied procedure. (2) In a second analysis of
the same data, diffusion and micro-circulation contribu-
tions were separated by biexponential fitting (assuming a
fast- and slow-decaying component with increasing b
values assigned to perfusion and diffusion contributions,
respectively) of the signal intensities at all multiple b
values. This analysis yielded (a) the “perfusion fraction”
(FP), i.e. the contribution of micro-circulation of blood and
movement in predefined structures such as renal tubules,
and (b) an ADC value (ADCD), reflecting predominantly
pure diffusion. From the results for each pixel, maps for the
different diffusion parameters were created and could be
displayed.
Ellipsoid regions of interest (ROIs) were positioned
on coronal T1-weighted images for anatomical guidance
and simultaneously on co-registered diffusion images at
b=0 s/mm2 or on calculated diffusion maps. The ROIs
were placed in the upper, mid and lower poles of the
cortex and medulla on several slices covering large parts
of the allograft (mean total number of ROIs 11.0±3.8
for both cortex and medulla; mean individual ROI size
0.47±0.02 cm3 and 0.45±0.02 cm3 for cortex and
medulla, respectively). Single total ROIs were created
separately for cortex and medulla by merging all
individual ROIs, yielding one ROI for the cortex and
one for the medulla. This procedure yields overall
cortical or medullary diffusion properties. However, in
order to assess possible focal changes in addition, which
might be missed or diluted otherwise, an individual ROI
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was placed in a “selected region” for each subject, i.e.
in a hypo- or hyperintense region within renal tissue on
the diffusion maps. This was performed no matter if this
region appeared to be within normal range or not. As
all processing steps, including diffusion map inspection
and ROI positioning, were performed blinded to the
results no bias was introduced by examining “selected
regions”.
Statistical analysis
For this initial study, which aims to determine the
feasibility of performing DW-MRI measurements in
renal allografts early after transplantation, a sample size
of ten patients with stable allograft function and of another
five patients with complications was considered sufficient.
A power analysis based on these numbers and on previous
DW-MRI results [8] yields a difference between deranged
and stable kidneys of less than 10% in ADCD and ADCT
and of approximately 40% in FP which could be detected
at a significance level of 0.05 and a statistical power of
80%. These calculated differences can be presumed
reasonable in view of previous results. However, a detailed
quantitative comparison between the groups was beyond
the scope of the present investigation.
Mean and standard deviations of ADCT, ADCD and FP
were calculated for the ten patients without clinical or
laboratory signs of transplant dysfunction and paired t tests
were performed for group comparisons between cortex and
medulla in stable allografts after testing for normal
distribution with a Kolmogorov–Smirnov Test. The
Mann–Whitney U test for unpaired samples was performed
for comparisons between stable allografts and kidneys with
acute rejection. However, because of the low number of
patients with transplant dysfunction, the results were
compared mainly descriptively as an indication of a
possible trend for differences between the groups. Diffu-
sion parameters were correlated with the estimated creat-
inine clearance by employing Pearson linear regression
analysis. A p value of less than 0.05 was considered
statistically significant. Statistical analysis was performed
with SPSS, version 12.0.1 (SPSS Inc., Chicago, Ill, USA).
Results
Stability of parameters from DW-MRI
No patient data had to be removed from the analysis
because of insufficient quality, i.e. all 15 investigated
subjects were included in the analysis. Mean values and
standard deviations of ADCT, ADCD and FP values in
medulla, cortex and in selected regions were calculated
from the ten patients with stable allograft function
(Table 2). Standard deviations for all ADC values were
low with coefficients of variation in the range of 4–7%,
while for FP the variance was greater with approximately
25%. ADCT and FP values were similar in cortex and
medulla. On the other hand, ADCD values were slightly,
but significantly, higher in cortex than in medulla (203±9
vs. 199±9×10−5 mm2/s, p<0.02).
Diffusion maps: examples and comparison
with histology
In two subjects (S1, S2) with second transplantation, but
stable allograft function, the DW-MRI measurement
covered both the recently transplanted functioning kidney
as well as the previously transplanted non-functioning
kidney within the same image planes. This allows for an
illustrative comparison of maps of the derived parameters
between the two kidneys (Fig. 1 shows the maps of S2) and
may provide a first impression of the sensitivity of this
method. The parameters ADCT, ADCD and especially the
perfusion fraction Fp were strongly reduced in the older and
insufficiently functioning kidneys compared with the new
allografts (Fig. 1). The overall values for the two older
allografts were ADCT=165 and 169×10
−5 mm2/s, ADCD=
157 and 153×10−5 mm2/s, FP=6 and 11%, for S1 and S2,
respectively.
DW-MRI parameter maps of an allograft with acute
rejection (see Table 1, patient S14) are shown in Fig. 2
together with the corresponding histological sections from
the transplant biopsy. The strongly reduced ADCT, ADCD
and FP in this subject (see Table 2) may correspond to
interstitial leukocytic infiltration, peritubular capillaritis
and/or tubular casts as shown on the histological section
(see Fig. 2).
Results from DW-MRI in kidneys with relevant
functional derangements
The ADCT values of the four grafts with histologically
proven evidence of acute rejection were lower than those of
eight (cortex and medulla) or nine (selected regions) of the
ten recipients with stable allograft function (Table 2). The
ADCT differences between the two patient groups were
significant for all tissue types (p<0.03).
Compared with ADCT, ADCD values, which mostly
represent pure diffusion, were relatively similar for all
subjects (Table 2). It is interesting to note that the only
kidney that had to be nephrectomised 50 days after the MR
measurement because of persistent acute humoral rejection
had by far the lowest ADCT and ADCD values in all the
regions investigated (S14 in Table 2). Remarkably,
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allografts with an acute rejection demonstrated reduced
micro-circulation contributions in medulla (p<0.03), cor-
tex (p<0.03) and in selected regions in the allograft (p<
0.01): FP values were lower in all four rejecting kidneys
than in 9/10 (cortex) and in 8/10 (medulla and selected
regions) kidneys with stable function (Fig. 3).
ADCT in the single patient with ATN and additional
signs of cholesterol emboli appeared slightly decreased
Fig. 1 Morphological MR images and parameter maps from DW-
MRI of one subject (S2) presenting first with an inadequately
functioning allograft (right side) and a well-functioning allograft
(left side). T1-weighted FLASH-MRI (a), maps for ADCT (b),
ADCD (c) and FP (d). The signal intensity was lower (darker shade)
on all diffusion maps of the first implanted (smaller) kidney
compared with the recently implanted kidney. The difference
between the first and the second allograft appears to be most
pronounced for FP and to a lesser extent for ADCD and ADCT. A
small haemorrhagic cyst in the upper pole and a small simple cyst in
the lower pole of the right kidney are visualised
Table 2 Results from DW-MRI in renal allografts with and without functional derangements
Diagnosis Subject Cortex Medulla Selected regiona
ADCT ADCD FP (%) ADCT ADCD FP (%) ADCT ADCD FP (%)
(10−5 mm2 /s) (10−5 mm2 /s) (10−5 mm2 /s)
Stable renal function S1 217 209 8 209 197 10 218 203 12
S2 240 207 23 246 204 27 241 204 24
S3 230 204 19 225 196 20 221 199 17
S4 200 183 12 194 180 10 192 175 13
S5 225 199 18 216 192 17 218 194 17
S6 246 211 25 241 208 24 240 210 21
S7 233 204 19 240 204 22 233 207 19
S8 240 214 19 234 203 21 221 193 20
S9 220 193 18 221 193 18 218 189 20
S10 234 209 18 234 210 18 235 208 19
Mean ± sd 228±14 203±9 18±5 226±16 199±9 19±5 224±15 198±11 18±4
ATN S11 209 198 8 215 203 9 211 206 6
Acute rejection S12 217 205 9 197 183 10 195 180 11
S13 205 193 10 203 192 9 198 189 9
S14 161 145 11 171 154 12 160 142 13
S15 219 206 11 212 199 10 214 209 6
Mean and standard deviation (sd) were calculated for allografts with normal function.
aA hypo- or hyperintense region on the diffusion maps (selected blinded to the results) that revealed deviations from normal appearance
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and, in particular, the micro-circulation contribution FP was
very low in all tissues investigated (Table 2 and Fig. 3).
Comparison between parameters from DW-MRI
and estimated glomerular filtration rate calculated
with the Cockcroft–Gault formula (eGFRc)
Significant correlations were determined between eGFRc
and the micro-circulation contribution (FP) in cortex (R=
0.53, p<0.05, Fig. 4a), medulla (R=0.52, p<0.05, Fig. 4b)
and selected regions (R=0.63, p<0.02, Fig. 4c). Estimated
GFRc did not correlate significantly with ADCT or ADCD
in any of the renal regions investigated.
Discussion
The results of this DW-MRI study on 3-TMRI demonstrate
that diffusion parameters can be determined in well-
functioning renal allografts shortly after transplantation
with low inter-patient variability, also including determi-
nation of micro-circulation contributions; the magnitude of
changes of the parameters assessed in subjects with
histologically proven acute rejection or ATN indicates
potential clinical utility of the method to non-invasively
monitor derangements in renal allografts.
Other non-invasive methods of detecting allograft
dysfunction
Many diagnostic attempts have been made to reduce the
need for an invasive transplant biopsy, considered the
“gold standard” for the diagnosis of parenchymal dysfunc-
tion, including acute rejection. Ultrasound characteristics
of rejection occur only late after rejection and are non-
specific [16]. The addition of serial measurements of
resistance index by colour-coded duplex ultrasound
Fig. 2 Morphological MRIs
(a), maps for ADCT (b), ADCD
(c), FP (d) and corresponding
histological section (e) for S14
presenting with signs of acute
humoral rejection, namely in-
terstitial oedema and peritubular
capillaritis (5), as well as a low-
grade interstitial infiltrate (3).
The morphological MR images
did not show any conspicuities.
For comparison, corresponding
MRIs (f–i) of a well-functioning
kidney and a normal histological
section (j) are also presented.
The arrows pinpoint 1 = inter-
stitial space, 2 = proximal tu-
bule, 3 = interstitial leukocytic
infiltration, 4 = tubular cast, 5 =
peritubular capillaritis (H&E
staining, bar = 100 µm)
Fig. 3 Perfusion fraction, FP (%), in cortex (a), medulla (b) and
“selected regions” (c) for transplanted kidneys with normal function
(N), acute rejection (AR) or acute tubular necrosis (ATN)
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increases the sensitivity, but specificity remains low [17,
18]. The diagnostic value of renal scintigraphy, especially
for prediction of acute rejection, is also limited [19].
The most consistent sign of acute rejection reported is
the loss of cortico-medullary differentiation on contrast-
enhanced MR renography [20], although it appears to be a
relatively non-specific finding in acute rejection, with
overlap with other disease processes [21]. Thus, other non-
invasive methods have to be considered, including MR-
based functional renal imaging.
Blood oxygen level-dependent (BOLD) MRI has been
shown to be of potential clinical value in transplanted
kidneys [8] and may be helpful for evaluation and
separation of kidney allograft dysfunction like ATN or
acute rejection [22, 23]. Previously we have shown that the
relaxation rate from BOLD MRI and FP from DW-MRI
provide complementary information [8]. Accordingly, a
comparison of the two methods in renal dysfunction would
be of interest. However, BOLD MRI in renal transplanta-
tion appears more challenging at 3 T than 1.5 Tand is prone
to artefacts, presently limiting its utility [24].
Stability of parameters from DW-MRI and diffusion
and perfusion separation
A separation of diffusion and perfusion contributions from
DW-MRI measurements was accomplished in the present
study, yielding ADCD, which reflects primarily pure
diffusion, and FP, the perfusion fraction, which reflects
micro-circulation of blood and/or movement of fluids in
predefined structures such as tubules and glomeruli. ADC
values and FP, although less marked, exhibited a low inter-
subject variability in the 10 stable functioning allografts
early after transplantation.
The separation of perfusion and diffusion parameters
from DW-MRI measurements was first proposed about
20 years ago by Le Bihan et al. [2] and has been discussed
ever since, also for imaging of abdominal organs [25–28].
The current investigation suggests that this separation may
be clinically useful and provides additional information
compared with the standard procedure of estimating only a
single ADC value, corresponding to ADCT in our analysis.
This separation may lead to a better differentiation between
different entities, as suggested in the present study when
the distinct parameters were compared between stable and
acutely rejected kidneys. Although speculative on the basis
of only four cases of rejection, the lower FP in grafts with
AR in the presence of relatively unchanged ADCD suggests
that lower micro-circulation rather than reduced diffusion
accounts for the lower ADCT. A similar finding was
observed recently in a DW-MRI study by Luciani et al. [26]
in patients with liver cirrhosis: While ADCD values
appeared unchanged, indicating unchanged diffusion, the
perfusion was decreased in cirrhotic patients. Without the
diffusion/perfusion separation, these changes would have
been missed, or erroneously attributed to altered diffusion.
In the current study, mean values and standard devia-
tions for ADCD and FP in patients with stable allograft
function 10±4 days after transplantation are very similar to
those of our previous investigation in 15 stable renal
allografts on average 9 months after transplantation,
despite differences in measurement parameters and field
strength [8] (previously, ADCD values (×10
−5 mm2/s) were
198±10 and 198±7 in cortex and medulla, respectively; FP
values were 19±4% and 18±5% in cortex and medulla,
respectively). The ADCT values were slightly higher in the
allografts of the current study compared with the previous
ones (previously, ADCT values (×10
−5 mm2/s) were 217±
14 and 217±11 in cortex and medulla, respectively). In line
with the present results, ADCT and FP were previously
found to be similar in cortex and medulla of transplanted
kidneys, a finding contrary to that of native kidneys with
higher ADC and FP values in cortex than in medulla [8]. In
our previous study, ADCD values determined in renal
allografts were also not different in medulla and cortex. In
the present investigation, however, ADCD values were
slightly higher in the cortex compared with the medulla.
This may be a spurious difference or may be due to the
different time point of the measurements after transplan-
tation. Nevertheless, the similarity between the previously
and currently determined values, obtained on various
imaging systems with different measurement parameters
and field strengths, suggests that the results may be
comparable in absolute terms across different studies or
institutions. However, the separation of micro-circulation
contributions and diffusion appears to be a prerequisite. If
this separation is neglected, the resulting ADC values will
Fig. 4 Correlation between es-
timated glomerular filtration rate
(eGFRc) calculated by the
Cockcroft–Gault formula and FP
(%) in cortex (a), medulla (b)
and selected regions (c). Black
diamonds normal function, red
diamonds acute rejection, blue
circle ATN
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depend on the measurement parameters, namely the
strength of parameters for diffusion weighting. This most
likely explains the anticipated differences between the
ADCT values in the previous and current studies. Similarly,
different diffusion-weighting parameters probably account
for inconsistencies and differences between published
“total” ADC values for native kidneys (for an overview
see e.g. [6, 29]).
Functional relevance and limitations of the study
The micro-perfusion contribution was lower in cortex,
medulla and “selected regions” of the four kidney
transplants with evidence of rejection compared with
stable transplants. The changes in AR were only slightly
more pronounced in “selected regions” (Fig. 3). Thus,
compared to overall cortical or medullary diffusion
properties the analysis of “selected regions” did not yield
a clearly superior separation of the few allografts with
dysfunction. Nevertheless, in combination with simple
determination of signal intensities of the diffusion maps the
rather strong ADCT and FP reductions in dysfunction may
suggest a clinical role for visual analysis of individual
diffusion maps.
The decreased FP paralleled a reduced estimated GFR.
These results are in line with observations by Jani et al.
[10], who quantified renal blood flow by para-aminohip-
puric acid and GFR by inulin clearance in patients with
acute rejection and observed a decrease in renal blood flow
by 45 to 70% and a reduced GFR. Besides the rejection
process, the impaired haemodynamics might partly be
explained by the administration of calcineurin inhibitors
[30]. However, since the immunosuppressive regime in all
our study patients was the same and calcineurin levels
comparable (results not shown), it is unlikely that
calcineurin inhibition accounts for the differences in
micro-circulation observed between patients with and
without functional derangements [31, 32]. Thus, according
to our preliminary results, FP may help to estimate changes
in renal blood flow non-invasively in different parts of the
kidney and provide further insight into mechanisms
accounting for impaired renal haemodynamics after renal
transplantation.
There are a number of limitations to our study: First,
although care was taken not to select regions for
determining diffusion parameters in the kidneys that were
close to the site of biopsy, it cannot be excluded that the
biopsy, which was performed mostly in patients with acute
rejection, may have affected the results. Second, the
patients with rejection had already been given a high
dose of methylprednisolone at the time of the MR
investigation. Although unlikely, we cannot exclude an
effect of this intervention independent of the histologically
proven rejection. Third, ROI placement and reading was
performed by only one reader and only once, potentially
introducing reader related bias and preventing determina-
tion of inter- and intra-rater reliability. Forth, the clinical
utility of the time-consuming and costly MR investigation
awaits confirmation in a larger cohort and no final
conclusion on its value in AR can currently be drawn.
This is especially true for the single ATN case: although the
finding of reduced micro-circulation is reasonable in a
physiological sense, it is not possible to draw any clinically
relevant conclusion on whether the method allows AR to
be distinguished from ATN.
Conclusion
The application of DW-MRI in renal allografts holds
promise as a tool for non-invasive detection and monitor-
ing of functional and structural derangements early after
transplantation.
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